“We Still Need Studies on the Value of the TIVAD for Cancer Patients?” by Isidoro Di Carlo and Adriana Toro.
References
Singh KR, Agarwal G, Nanda G, Chand G, Mishra A, Agarwal A, Verma AK, Mishra SK, Goyal P (2013) Morbidity of chemotherapy administration and satisfaction in breast cancer patients: a comparative study of totally implantable venous access device (TIVAD) versus peripheral venous access usage. World J Surg. doi:10.1007/s00268-013-2378-x
Kreis H, Loehberg CR, Lux MP et al (2007) Patients’ attitudes to totally implantable venous access port systems for gynecological or breast malignancies. Eur J Surg Oncol 33(1):39–43
Agarwal G, Pradeep PV, Aggarwal V et al (2007) Spectrum of breast cancer in Asian women. World J Surg 31:1031–1040. doi:10.1007/s00268-005-0585-9
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Singh, K.R., Agarwal, G. Prioritizing the Expenses of Breast Cancer Treatment Makes Sense- not Just in Developing Countries, but Across the Globe. World J Surg 38, 2187–2188 (2014). https://doi.org/10.1007/s00268-014-2565-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-014-2565-4